ESTRO 2024 - Abstract Book

S1439

Clinical - Head & neck

ESTRO 2024

Results:

657 patients met the eligibility criteria; patient characteristics are shown in the Table.

N = 657 1

Characteristic

Age

59 (52, 65)

Female

127 (19%)

ECOG performance status

0

453 (69%)

1

159 (24%)

2

35 (5.3%)

3

8 (1.2%)

ACE-27 score

0

333 (51%)

1

204 (31%)

2

87 (13%)

3

33 (5.0%)

Current smoker (yes)

187 (29%)

>= 10 pack-year history

299 (46%)

Tumour stage (TNMv7)

T1

137 (21%)

T2

240 (37%)

T3

132 (20%)

T4a

128 (19%)

T4b

20 (3.0%)

Nodal stage (TNMv7)

N0

35 (5.3%)

N1

107 (16%)

N2a

69 (11%)

N2b

302 (46%)

N2c

116 (18%)

N3

28 (4.3%)

Intensified treatment (yes)

384 (58%)

1 Median (IQR); n (%)